The number of people living in D.C. is booming, and so too is the number of rats. Kojo talks about how D.C.'s rodent problem is affecting the city and what's being done to fight off the pests.
Guest Host: Jen Golbeck
The chief executive of a pharmaceutical company caused a public outcry when he acquired sole U.S. rights to distribute a lifesaving drug and raised the price by more than 5000 percent. But the issue goes well beyond one company and one former hedge fund manager. A number of companies have been quietly cornering the market on older, off-patent drugs–and hiking prices. We speak with a medical historian about the economics of drug pricing, and why “generic” doesn’t guarantee competition.
- Jeremy Greene MD; Professor of Medicine and the History of Medicine, Johns Hopkins University School of Medicine; Author, “Generic: The Unbranding of Modern Medicine.”
Most Recent Shows
The federal court judge who ruled that Maryland's public universities were unlawfully segregated rejected solutions proposed by the state's Higher Education Commission and a group representing a coalition of Maryland Historically Black Colleges and Universities for redressing that segregation. We get an update on the case.
A new book, "Chocolate City: A History of Race and Democracy in the Nation's Capital," presents a sweeping view of how race impacted Washington, D.C. for the past four centuries.
Developers and new residents are eying Reston, Virginia, and Fairfax County officials want to change zoning rules to allow them to move in. But in a trend that is playing out across the region, many long-time residents say their community is becoming too urban too fast.